EBUS-guided TBNA for Molecular Diagnostic of Mediastinal Lymph Nodes (LN)

Heidelberg University50 enrolled

Overview

The purpose of this study is to perform molecular diagnostic in mediastinal lymph nodes of non-small cell lung cancer patients sampled by endobronchial ultrasound guided finde needle aspiration (EBUS-TBNA).

NSCLC is a common cancer. Accurate and early staging has a significant impact on outcome. EBUS-TBNA of involved mediastinal lymph nodes is critical. Molecular markers could improve mediastinal staging.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Non Small Cell Lung Cancer

Interventions

EBUS_TBNAPROCEDURE

EBUS during bronchoscopy

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age ≥ 18 years * Samples are collected before surgery or before any therapy * ECOG 0 or 1 * Clinical stage I-II, T1-2, N0-1, M0) * Surgically respectable * Patient with enlarged med. lymphnodes (control group) Exclusion Criteria: * Previous RT/CHT * Previous or current cancer of other entity

Locations (1)

Thoraxklinik Heidelberg, Dept. of Pneumology and Respiratory Critical care

Heidelberg, Germany

RECRUITING

Central Contacts

Michael Kreuter, MD

CONTACT

49 / 6221 / 396 michael.kreuter@thoraxklinik-heidelberg.de

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.